Exclusive: ACR Convergence 2024| Focus Rheums

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

Tips for Smoothing the Time-Consuming Prior Authorization Process

  |  Issue: January 2020  |  

Susan Bernstein is a freelance journalist based in Atlanta.

References

  1. American Medical Association. 2017 AMA prior authorization physician survey.
  2. Wallace ZS, Harkness T, Fu X, et al. Treatment delays associated with prior authorizations for infusible medications: A cohort study. Arthritis Care Res (Hoboken). 2019 Sep 10.
  3. Maine Bureau of Insurance. Quarterly report of formulary changes for 1st quarter 2019: January 1 through March 31, 2019. 2019 Jul.
  4. Snow J, Feldman, MA, Koppel J. The impact of step-therapy policies on patients. White paper. Questex LLC.
  5. Boytsov N, Zhang X, Evans KA, Johnson BH. Impact of plan-level access restrictions on effectiveness of biologics among patients with rheumatoid or psoriatic arthritis. Pharmacoecon Open. 2019 Jun 8; doi: 10.1007/s41669-019-0152-1. [Epub ahead of print].
  6. Illinois General Assembly. Bill status of HB0465: 101st General Assembly.

Related Articles

    Ethics Forum: The Ethical Considerations of Prior Authorization

    The mother of a 15-year-old patient with juvenile idiopathic arthritis/enthesitis-related arthritis (JIA/ERA) called the office in tears. She said she was having an insurance problem. Her son had been a star track athlete when he developed severe back pain. Magnetic resonance imaging showed evidence of severe sacroiliitis. He was started on a tumor necrosis factor…

    Prior Authorization Is Under Review

    I just couldn’t believe it. Like all of you, I receive many requests to see patients urgently. And like all of you, I can’t possibly accommodate all of those requests. So I triage: I look through the referrals and try to differentiate patients who want to be seen from those who need to be seen….